August J. Troendle, President and CEO of Medpace Holdings, Inc. (NASDAQ:MEDP), filed a Form 4 on September 21, 2026, disclosing the sale of 10,880 shares of common stock on September 17, 2026.

Key Highlights

  • Shares sold: 10,880 shares of Medpace Holdings common stock disposed of on September 17, 2026.
  • Weighted average price: $620.40 per share, with individual transactions ranging from $620.00 to $622.21.
  • Direct ownership following sale: 504,273 shares held directly by the reporting person.
  • Indirect ownership: 4,733,019 shares held indirectly through Medpace Investors, LLC, of which Troendle is the sole manager and controlling unit holder.
  • Transaction basis: The filing states the sale was effected pursuant to a limit order placed during an open window period.
  • Roles disclosed: Troendle is identified as Director, Officer (President and CEO), and 10% Owner of Medpace Holdings.

Troendle's Share Sale and Beneficial Ownership at Medpace Holdings

According to the Form 4 filed with the U.S. Securities and Exchange Commission, August J. Troendle sold 10,880 shares of Medpace Holdings, Inc. common stock on September 17, 2026, at a weighted average price of $620.40 per share. The filing notes that the shares were sold in multiple transactions at prices ranging from $620.00 to $622.21, and that Troendle undertakes to provide full pricing information to the issuer, any security holder, or SEC staff upon request.

The filing discloses that the transaction was carried out pursuant to a limit order placed by Troendle during an open window period. Following the reported sale, Troendle directly holds 504,273 shares of common stock. In addition, the filing reports 4,733,019 shares held indirectly through Medpace Investors, LLC. According to the filing, Troendle is the sole manager and controlling unit holder of Medpace Investors, LLC and "has sole voting and investment control with respect to the securities held by MPI." The filing further states that Troendle "may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."

The Form 4 was signed by Stephen P. Ewald as Attorney-in-Fact for August J. Troendle and submitted on September 21, 2026. No derivative securities transactions were reported in Table II of the filing.

What Was Disclosed

The filing reports a single open-market sale of 10,880 shares by Medpace Holdings' President and CEO on September 17, 2026, at a weighted average price of $620.40, along with the reporting person's resulting direct and indirect beneficial ownership positions.